Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Prospective study of chemotherapy in patients with metastatic gastrinoma.

von Schrenck T, Howard JM, Doppman JL, Norton JA, Maton PN, Smith FP, Vinayek R, Frucht H, Wank SA, Gardner JD, et al.

Gastroenterology. 1988 Jun;94(6):1326-34.

PMID:
2966088
2.

Aggressive resection of metastatic disease in selected patients with malignant gastrinoma.

Norton JA, Sugarbaker PH, Doppman JL, Wesley RA, Maton PN, Gardner JD, Jensen RT.

Ann Surg. 1986 Apr;203(4):352-9.

3.
4.
5.
6.

Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.

Pisegna JR, Norton JA, Slimak GG, Metz DC, Maton PN, Gardner JD, Jensen RT.

Gastroenterology. 1992 Mar;102(3):767-78.

PMID:
1537514
7.
8.

Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.

Frucht H, Howard JM, Stark HA, McCarthy DM, Maton PN, Gardner JD, Jensen RT.

Am J Med. 1989 Nov;87(5):528-36.

PMID:
2573280
9.

Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study.

Maton PN, Vinayek R, Frucht H, McArthur KA, Miller LS, Saeed ZA, Gardner JD, Jensen RT.

Gastroenterology. 1989 Oct;97(4):827-36.

PMID:
2777040
10.

Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.

Hirschowitz BI, Mohnen J, Shaw S.

Aliment Pharmacol Ther. 1996 Aug;10(4):507-22.

PMID:
8853754
11.

Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.

Shojamanesh H, Gibril F, Louie A, Ojeaburu JV, Bashir S, Abou-Saif A, Jensen RT.

Cancer. 2002 Jan 15;94(2):331-43.

12.

Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study.

Norton JA, Cornelius MJ, Doppman JL, Maton PN, Gardner JD, Jensen RT.

Surgery. 1987 Dec;102(6):958-66.

PMID:
2891201
13.

Prospective study of the need for long-term antisecretory therapy in patients with Zollinger-Ellison syndrome following successful curative gastrinoma resection.

Metz DC, Benya RV, Fishbeyn VA, Pisegna JR, Orbuch M, Strader DB, Norton JA, Jensen RT.

Aliment Pharmacol Ther. 1993 Jun;7(3):247-57.

PMID:
8364130
14.
15.
17.

Successful treatment of a malignant gastrinoma with streptozotocin.

Hayes JR, O'Connell N, O'Neill T, Fennelly JJ, Weir DG.

Gut. 1976 Apr;17(4):285-8. Review.

18.

Evaluation of NH2-terminus gastrins in gastrinoma syndrome.

Kothary PC, Fabri PJ, Gower W, O'Dorisio TM, Ellis J, Vinik AI.

J Clin Endocrinol Metab. 1986 May;62(5):970-4.

PMID:
2870076
19.

Prospective study of the ability of serial measurements of serum chromogranin A and gastrin to detect changes in tumor burden in patients with gastrinomas.

Abou-Saif A, Gibril F, Ojeaburu JV, Bashir S, Entsuah LK, Asgharian B, Jensen RT.

Cancer. 2003 Jul 15;98(2):249-61.

20.

Supplemental Content

Support Center